Focal Adhesion Kinase (FAK) is a promising therapeutic target that is overexpressed and phosphorylated in a variety of cancers including thyroid cancer to drive growth, survival, migration, and metastasis (3–13). This evidence concerns the gene PTK2 and thyroid cancer.